Lin Zhang

12PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 01, 2026
Epigenetic Reactivation of TNFRSF19 Suppresses Mitophagy and Sensitizes Triple-Negative Breast Cancer to Doxorubicin.

|May 26, 2026
Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis.

|Apr 01, 2026
Solamargin-functionalized gold nanoparticles codelivering photothermal-immunotherapy for triple-negative breast cancer.

Zhengwei Gui, Lu Zhao, Shiyang Liu

|Nov 29, 2025
Pregnancy-associated breast cancer: gestational weight gain impact and nomogram validation.

Chenguang Liu, Ruifeng Wang, Shoujun Wang

|Nov 22, 2023
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells.

Shiyang Liu, Yao Tian, Chenguang Liu

|Nov 13, 2023
PI3K/AKT signaling activates HIF1α to modulate the biological effects of invasive breast cancer with microcalcification.

Yao Tian, Lu Zhao, Zhengwei Gui

Pageof 2

Frequent Collaborators

3 joint publications

Zhengwei Gui

2 joint publications

Yao Tian

1 joint publications

Xiaofei Tong